Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Graphic Controls D.B.A. Vermed

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Graphic Controls D.B.A. Vermed

Regulatory records
2
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 2 FDA records to the applicant name Graphic Controls D.B.A. Vermed. 1 entry is a PMA supplement. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Nov 12, 2025 to Dec 19, 2025. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MKJ appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P200007, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 400 Exchange St., Buffalo, NY, 14204. Recorded on P200007/S002, decision dated Dec 19, 2025.

Changes described in PMA records

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Graphic Controls D.B.A. VermedPMA supplementDec 19, 2025FDA
Graphic Controls D.B.A. VermedPMA supplementNov 12, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.